Merus N.V. vs Microbiotica
Merus N.V.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c
185 employees · est. 2003 · Utrecht, The Netherlands
Microbiotica
The microbiome is a new approach to medicine, offering potential for significant advancements. Microbiotica aims to remove translation challenges
49 employees · est. 2016 · Cambridge, United Kingdom
Merus N.V. is the older company (2003 vs 2016); Merus N.V. is the larger of the two.
Side-by-Side Comparison
| Metric | Merus N.V. | Microbiotica |
|---|---|---|
| Founded | ||
| Founded | 2003 older | 2016 |
| Headquarters | ||
| Headquarters | Utrecht, The Netherlands | Cambridge, United Kingdom |
| Employees | ||
| Employees | 185 larger | 49 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Venture round |
| Total Funding | ||
| Total Funding | $1.04B | $62.00M |
| Funding Rounds | ||
| Funding Rounds | 11 | 4 |
| Services | ||
| Services | Development of Cancer Treatments, Clinical Trials Management, Research and Development in Biotechnology, Multiclonics Therapeutics | Development and commercialization of clinic-ready defined live biotherapeutic products for immuno-oncology and inflammatory bowel disease |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Medical Researchers, Pharmaceutical Industry | Patients suffering from immuno-oncology and inflammatory bowel diseases, healthcare providers, pharmaceutical companies, and research institutions |
| Taxonomy | ||
| Taxonomy | Biclonics®Bispecific Antibody TherapeuticsAntibody-based BiopharmaceuticalsOligoclonics TechnologyImmuno-oncologyCancer Treatment +9 | MicrobiomeBiotechResearchClinical TrialsCancerOncology +6 |
| Website | ||
| Website | merus.nl | microbiotica.com |
About Merus N.V.
Merus N.V., a biotechnology firm founded in 2003, is headquartered in The Netherlands. The company is at the forefront of developing innovative oncology solutions using its proprietary Biclonics® bispecific antibody therapeutics. This pioneering approach enables simultaneous multi-targeted tumor att...
About Microbiotica
Microbiotica is a biotechnology company founded in 2016, headquartered in the United Kingdom. The company focuses on leveraging the microbiome as a novel approach to medicine, aiming to address translation challenges in the field. With a background rooted in a decade-long investment at the Wellcome...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Merus N.V. and Microbiotica for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Merus N.V. or Microbiotica moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Merus N.V. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Merus N.V. on 15 Jun 2026, and Microbiotica on 24 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
